Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy
{{output}}
The IL-6/JAK/STAT3 signaling pathway is a key regulator of tumor progression, immune evasion, and therapy resistance in various cancers. Frequently dysregulated in malignancies, this pathway drives cancer cell growth, survival, angiogenesis, and metastasis by ... ...
